Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers

Head and neck cancer is the 6th most common malignancy worldwide and urgently requires novel therapy methods to change the situation of low 5-years survival rate and poor prognosis. Targeted therapy provides more precision, higher efficiency while lower adverse effects than traditional treatments li...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bo, Liu, Tingjun, Qu, Yang, Liu, Hangbo, Zheng, Song Guo, Cheng, Bin, Sun, Jianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279860/
https://www.ncbi.nlm.nih.gov/pubmed/30547012
http://dx.doi.org/10.3389/fonc.2018.00563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279860/
https://www.ncbi.nlm.nih.gov/pubmed/30547012
http://dx.doi.org/10.3389/fonc.2018.00563

Ejemplares similares